DTx Pharma to Participate in the 2021 BMO BioPharma Day: Spotlight on Rare Disease and Ophthalmologyykarakaya2021-06-16T10:40:44-07:00June 16th, 2021|Read More
DTx Pharma Appoints Jill Howe as Chief Financial OfficerAhmet2021-06-07T06:22:17-07:00June 7th, 2021|Read More
Biocentury | DTx: Optimizing RNA therapies for cellular uptake, biodistributionykarakaya2021-06-02T08:28:04-07:00June 2nd, 2021|Read More
DTx Pharma to Participate in Upcoming Virtual Investor Conferencesykarakaya2021-06-01T09:44:10-07:00May 26th, 2021|Read More
DTx Pharma to Participate in the 2021 Needham Virtual Healthcare Conferenceadamdtx2021-04-22T13:53:58-07:00April 7th, 2021|Read More
DTx Pharma Completes $100M Series B Financing to Advance its FALCON™ Platform and Pipeline of RNA Therapeuticsadamdtx2021-04-22T13:54:29-07:00March 1st, 2021|Read More
